PharmD

1
(No Transcript)
2
Welcome to Doctor of Pharmacy (PHARM.D.) PROGRAM

• PCI President Dr B Suresh who brought Doctor of
  Pharmacy Program to India
• About 62 of licensed pharmacists work in
  community pharmacies and 23 work in hospitals
• About 71 of Pharmacy Technician jobs are in
  pharmacies, grocery stores, department stores, or
  mass retailers.

3
Pharm D Graduates ..?

• Pharmacy council of India started the programme
  in the year 2008 with a good intention to improve
  the pharmacy services in the Indian healthcare
  system and to increase the dignity of the
  profession. But, from the beginning a group of
  people have been raising allegations about the
  way the programme was introduced and the way it
  is disturbing the smooth running of the course
  putting the students into a quandary.
• http//www.acharya.ac.in/pharmd.html

4
what would be job prospects for Pharm D in India ?

• A Pharm D graduate could find jobs mostly related
  to the clinical force of India. With gradual
  amendments being made in the health care
  industry, the Pharm D graduate could play an
  active role in heading the Hospital Pharmacy
  Setting (Hospital Setting / Hospital Pharmacy.
• Also with a large number of Pharmaceutical
  companies opting for clinical trials the industry
  is heading towards a business worth 1.4 billion
  by way of clinical trials.

5
Health care system In USA

• Hospital Pharmacy
• Community Pharmacy
• Clinical Pharmacy
• Clinical Pharmacokinetics
• Clinical trial safety

6
REGISTRATION AS PHARMACIST IN INDIA AND OTHER
COUNTRIES
7
What kind of jobs should pharm D expect ?
8
How drugs works
9
Future Challenges
Indian Government has come out with a
recommendation that ADRs should be collected for
all drugs by all pharmaceutical companies,
hospitals, clinician treating the patients and
practicing clinicians. To take the plan forward,
official sources said that MCI should be
requested to take forward the process of
sensitizing clinicians in the hospitals to report
ADRs to the Pharmacovigilance Programme of India
(PvPI). Recommendation is a part of the meeting
held with the officials of the Pharmacy Council
of India  and Indian Council of Medial Research
(ICMR) recently.

10
FIPO urges govt to increase quantum of study
leave to enable pharmacists to do Pharm D
programme
The Federation of Indian Pharmacists Organization
(FIPO) has urged the Department of Personnel
Training (DoPT), government of India to revise
the Rule 51 of the Central Civil Services Leave
Rules (CCS) in order to facilitate the
pharmacists in the central government health
services to pursue higher studies in pharmacy,
especially the three-year Pharm D (PB) programme
11
Job Opportunities

• Hospital Pharmacy
• Community Pharmacy
• Clinical Pharmacy
• Clinical Pharmacokinetics
• Clinical trial safety

12
Job Opportunities

• Pharmacovigilance
• Pharmaco-economics
• Adverse Drug Reactions (ADRs)
• Clinical Research Organizations
• Biostatistics and Research Methodology

13
Job Opportunities

• Clinical Toxicology
• Clinical Research, Pharmacoepidemiology
• Pharmacotherapeutic Drug Monitoring
• Clinical Pharmacokinetics
• Pharmacoeconomics
• Drug Safety
• Forensic Pharmacy
• Forensic Psychology

14
Pharm D graduates eligible to write FRGEE in USA

• Foreign Pharmacy Graduate Examination Committee
  (FPGEC)

15
Surveillance Programmes In India
16
PHARMACOVIGILANCE CURRENT SCENARIO FUTURE
CHALLENGES IN INDIA

• BY V . PRAJITH

17
CONTENTS

• Introduction why Pharmacovigilance
• Aim of Pharmacovigilance
• Pharmacovigilance Future Challenges, Need
  issues
• Outcome of successful Program in
  Pharmacovigilance
• Summery Conclusion

18
Introduction why Pharmacovigilance

• Pharmacovigilance Programme of India launched on
  July 14, 2010 is currently capturing ADR data in
  Indian population in a systematic way in
  coordination with the IPC. The main objective of
  the Programme is to monitor ADRs in Indian
  population.
• Safety Monitoring of Medicinal Products
• Pharmacovigilance (PV or PhV), also known as Drug
  Safety

19
Aim of Pharmacovigilance

• All medicines have risks as well as benefits. The
  aim of Pharmacovigilance 1 is to protect public
  health by identifying, evaluating, managing and
  minimizing safety Issues to ensure that the
  overall benefits of medicines outweigh the risks.
  
• Patient safety is a fundamental principle
• Apply computerized statistical tool s to
  facilitate the evaluation of safety information
  through, for example, the identification of
  unexpected adverse events that are being reported
  on a disproportionate basis (safety signals)
• The science of Pharmacovigilance is continuously
  evolving and is actively involved in working
  with industry, regulators, healthcare
  professionals and patients to enhance
  methodologies in this area

20
Aim of Pharmacovigilance

• Drug Technical Advisory Board (DTAB) set up
  Vigilance Cells
• Forensic Pharmacy and Forensic Psychology
• Adverse Drug Reactions (ADRs)
• Clinical Trial Safety

21
Outcome of successful Program in Pharmacovigilance

• In this regard, IPC which acts as the national
  coordination centre (NCC) for Pharmacovigilance
  Program of India (PvPI) already had a series of
  strategic meetings with the Centre over the last
  few months.
• Since 2011, around 1,10,000 adverse drug
  reactions have been reported from across the
  country. However, this was after the government
  made it mandatory for hospitals to have a
  pharmacovigilance cell. Still, officials say,
  there are only few hospitals across the country
  operating with a proper cell.
• Currently, there are only 150 hospitals across
  the country which have pharmacovigilance cell,
  the official cell. However, the health ministry
  and the drug regulator are making efforts to ramp
  up such cells.

22
Surveillance Programmes
23
Summery Conclusion

24
V.PRAJITH
25
(No Transcript)